News
Public · Published
RWA perps are getting serious on Injective... In the last 30 days, the @injective network has played host to some $215M in RWA perps volume, the majority of which was based around tokenised equities. Injective has experienced a renaissance of its ecosystem in 2026, hitting an
The Injective network hosted around $215 million in real-world asset perpetual futures trading volume over the last 30 days, with most of that volume based on tokenised equities, according to a post by BSCNews on X.
Published:
Updated:
What happened
The Injective network hosted around $215 million in real-world asset perpetual futures trading volume over the last 30 days, with most of that volume based on tokenised equities, according to a post by BSCNews on X.
Confirmed
Global impact / market context
This trading volume shows growing interest in tokenised equities, which are digital tokens representing company shares. If demand continues, Injective could attract more users and fees, potentially boosting activity for apps built on its network and increasing its overall value.
Analyst inference
Perpetual futures are contracts without an expiry date, letting traders bet on price moves. Strong volume on Injective suggests blockchain platforms can handle real-world assets, possibly drawing attention from investors seeking alternative ways to trade traditional markets. This could pressure other networks to expand similar offerings.
Analyst inference
What to watch
- Monitor whether Injective's $215 million in real-world asset perpetual futures volume continues to grow or slows down over the coming weeks, as this will indicate sustained interest in tokenised equities trading. Confirmed
- Watch for announcements from Injective about new partnerships with companies that offer tokenised equities, since added listings could expand the range of tradeable assets and increase trading activity further. Proposed
- Track whether other blockchain networks introduce similar tokenised equity perpetual futures products, since competitive responses could shift trading volume away from Injective and reshape market share across platforms. Analyst inference